UDI: Value Beyond Compliance
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.
Related Resources
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Supply Chain Strategies & Solutions Article
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based valu
Toolkits/Methodology
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Request for Proposals (RFP)
A sample of wholesale pharmacy distributor request for proposal.
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…